Clinical pharmacology of ibuprofen in preterm infants: A meta-analysis of published data

High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study.

Improved Closure of Patent Ductus Arteriosus With High Doses of Ibuprofen

Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis.

Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants.

Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants.

Serum ibuprofen levels of extremely preterm infants treated prophylactically with oral ibuprofen to prevent patent ductus arteriosus

Unbound bilirubin does not increase during ibuprofen treatment of patent ductus arteriosus in preterm infants.

Comparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohorts

Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus.

Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?

Clinical pharmacology of ibuprofen in preterm infants: A meta-analysis of published data

High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study.

Improved Closure of Patent Ductus Arteriosus With High Doses of Ibuprofen

Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis.

Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants.

Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants.

Serum ibuprofen levels of extremely preterm infants treated prophylactically with oral ibuprofen to prevent patent ductus arteriosus

Unbound bilirubin does not increase during ibuprofen treatment of patent ductus arteriosus in preterm infants.

Comparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohorts

Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus.

Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?

Clinical pharmacology of ibuprofen in preterm infants: A meta-analysis of published data

High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study.

Improved Closure of Patent Ductus Arteriosus With High Doses of Ibuprofen

Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis.

Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants.

Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants.

Serum ibuprofen levels of extremely preterm infants treated prophylactically with oral ibuprofen to prevent patent ductus arteriosus

Unbound bilirubin does not increase during ibuprofen treatment of patent ductus arteriosus in preterm infants.

Comparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohorts

Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus.

Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?